Prevnar 13
Payments companies reported to CMS as associated with Prevnar 13. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prevnar 13, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prevnar 13
These are the largest totals companies reported as associated with Prevnar 13. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jana Shaw | Watertown, NY | Pediatric Infectious Diseases | $23,217.20 |
| Jaime Fergie | Corpus Christi, TX | Pediatric Infectious Diseases | $12,558.97 |
| Julio Ramirez | Louisville, KY | Infectious Disease | $12,225.00 |
| Stephen Thomas | Syracuse, NY | Infectious Disease | $11,289.64 |
| Jessica Boyd | Washington, DC | Pediatrics | $7,280.00 |
| Paul Luning | Oak Park, IL | Family Medicine | $7,125.00 |
| Rajiv Modak | Tucson, AZ | Pediatrics | $7,125.00 |
| Davida Gerena | Des Plaines, IL | Pediatrics | $6,550.98 |
| Eric Simoes | Aurora, CO | Pediatric Infectious Diseases | $5,200.00 |
| Joel Tanaka | Fort Carson, CO | Family Medicine | $4,950.00 |
Prescribed Prevnar 13?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.